Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Trius Therapeutics Inc (TSRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/11/2013 |
4/A
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 3,000 shares
@ $7.475, valued at
$22.4k
|
|
| 05/28/2013 |
4/A
| Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 12,000 shares
@ $7.85, valued at
$94.2k
|
|
| 05/28/2013 |
4/A
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 12,000 shares
@ $7.65, valued at
$91.8k
|
|
| 11/02/2011 |
4/A
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 08/18/2010 |
4/A
| SOFINNOVA VENTURE PARTNERS VII L P (10% Owner) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Converted 1,892,177 shares
@ $0
Converted 893,395 shares
@ $4.38, valued at
$3.9M
Bought 830,000 shares
@ $5, valued at
$4.2M
Converted 10,909,092 options to buy
@ $0
Converted 5,363,636 options to buy
@ $0 |
|
|
|